Regina G. Kelmann

Pharmacology, Toxicology and PharmaceuticsAgricultural and Biological SciencesMedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model”.

Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model

JCI Insight(2023)10.1172/jci.insight.171140

N/A

0DataRank · unranked

17 citations

Richard D. Lutze, Chithra K. Pushpan, Regina G. Kelmann, Huizhan Liu, M. May +4 more

KSR1 knockout mouse model demonstrates MAPK pathway’s key role in cisplatin- and noise-induced hearing loss

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.08.566316

N/A

0DataRank · unranked

3 citations

Richard D. Lutze, Regina G. Kelmann, Daniel F. Kresock, Jordan D. Marsh, René Vielman Quevedo +3 more

Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss

Pharmaceuticals(2024)10.3390/ph17060735

N/A

0DataRank · unranked

3 citations

Matthew A. Ingersoll, Regina G. Kelmann, Tal Teitz, Richard D. Lutze

KSR1 knockout mouse model demonstrates MAPK pathway's key role in cisplatin- and noise-induced hearing loss

Journal of Neuroscience(2024)10.1523/jneurosci.2174-23.2024

N/A

0DataRank · unranked

9 citations

Richard D. Lutze, Regina G. Kelmann, Daniel F. Kresock, Jordan D. Marsh, René Vielman Quevedo +3 more

Oseltamivir (Tamiflu), a Commonly Prescribed Antiviral Drug, Mitigates Hearing Loss in Mice

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.06.592815

N/A

0DataRank · unranked

1 citations

Richard D. Lutze, Matthew A. Ingersoll, Regina G. Kelmann, K.H. Ly, Duane Currier +4 more

FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.05.20.595056

N/A

0DataRank · unranked

0 citations

Matthew A. Ingersoll, Regina G. Kelmann, Tal Teitz, Richard D. Lutze